Huakang Pharma reports 29.92% YoY increase in H1 revenue

On 11 Aug., Zhejiang Huakang Pharmaceutical Co., Ltd. (Huakang Pharma) published its financial results for Q1 2022. Key financial highlights for H1 2022:Revenue: USD140.80 million (RMB949.97 million), an increase of 29.92% YoYNet profit attributable ...

Sorbitol China News 202208

www.cnchemicals.com